Hua Medicine (Shanghai) Ltd. (HKG:2552)
Hong Kong · Delayed Price · Currency is HKD 2.600
-0.030 (-1.14%)
Jun 1, 2026, 4:08 PM HKT
Hua Medicine (Shanghai) Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 1,106 | -250.14 | -211.23 | -203.51 | -325.73 |
Depreciation & Amortization | 31.9 | 33.96 | 35.67 | 31.3 | 30.84 |
Other Amortization | 0.57 | 0.62 | 0.57 | 0.48 | 0.75 |
Loss (Gain) From Sale of Assets | - | - | -0.04 | - | 0.08 |
Stock-Based Compensation | 12.19 | 11.84 | 23.91 | 21.28 | 32.7 |
Other Operating Activities | -1,245 | -106.25 | -90.5 | -52.53 | 7.56 |
Change in Accounts Receivable | -38.69 | -15.02 | 372.75 | -413.24 | -13.62 |
Change in Inventory | 5.01 | -82.04 | -42.72 | -1.9 | - |
Change in Accounts Payable | 49.77 | 2.88 | 38.27 | -0.01 | -2.51 |
Change in Unearned Revenue | - | - | 756.99 | 366.53 | - |
Change in Other Net Operating Assets | 25.75 | -13.81 | 5.7 | 21.48 | -3.03 |
Operating Cash Flow | -52.15 | -417.97 | 889.37 | -230.11 | -272.98 |
Capital Expenditures | -7.55 | -2.83 | -9.74 | -4.56 | -20.2 |
Sale of Property, Plant & Equipment | - | - | 0.07 | - | 0.07 |
Cash Acquisitions | - | - | - | -0.71 | - |
Sale (Purchase) of Intangibles | - | -1.03 | -0.1 | -22.91 | -6.39 |
Other Investing Activities | 6.89 | 13.9 | 17.85 | 23.42 | -41.71 |
Investing Cash Flow | -0.65 | 10.04 | 8.08 | -4.75 | -68.22 |
Long-Term Debt Issued | 112.43 | 133.15 | 200 | 28.92 | - |
Long-Term Debt Repaid | -119.62 | -44.26 | -135.74 | -18.36 | -16.48 |
Total Debt Repaid | -119.62 | -44.26 | -135.74 | -18.36 | -16.48 |
Net Debt Issued (Repaid) | -7.19 | 88.89 | 64.26 | 10.56 | -16.48 |
Issuance of Common Stock | 22.46 | 1.61 | 9.89 | 11 | 10.35 |
Other Financing Activities | -6.18 | -6.78 | -5.08 | -0.09 | - |
Financing Cash Flow | 9.1 | 83.72 | 69.07 | 21.48 | -6.13 |
Foreign Exchange Rate Adjustments | -3.76 | 3.13 | 3.68 | 28.78 | -9.52 |
Net Cash Flow | -47.47 | -321.07 | 970.19 | -184.61 | -356.85 |
Free Cash Flow | -59.7 | -420.8 | 879.63 | -234.67 | -293.18 |
Free Cash Flow Margin | -12.11% | -164.44% | 1148.19% | -1333.44% | - |
Free Cash Flow Per Share | -0.06 | -0.43 | 0.90 | -0.24 | -0.31 |
Cash Interest Paid | 6.18 | 6.78 | 5.08 | 0.09 | - |
Levered Free Cash Flow | -119.06 | -268.93 | 249.64 | -524.53 | -183.45 |
Unlevered Free Cash Flow | -113.96 | -263.55 | 254.58 | -522.24 | -180.98 |
Change in Working Capital | 41.83 | -107.99 | 1,131 | -27.13 | -19.17 |